Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AcumenBioFin was the dedicated life sciences investment banking division of Rodman & Renshaw Capital Group, Inc. Established in 2002, the division provided specialized financial services including capital raising, strategic advisory, and equity research for companies in the biotechnology, specialty pharmaceutical, and medical device sectors. It was particularly well-known for its leadership in Private Investment in Public Equity (PIPE) and Registered Direct (RD) financing transactions, often ranking as a top placement agent in the sector. The division also hosted the influential Rodman & Renshaw Annual Healthcare Conference, which served as a major networking hub for the biotech industry and institutional investors. AcumenBioFin ceased operations following the bankruptcy and subsequent liquidation of its parent company in 2012.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ACUMENBioFin.